Park Ha Biological Tech Co. L
13F holders, Q1 2026 (March 31)3holders
$1.04avg. 13F price*
At the end of Q1 2026, 3 institutions reported holding Park Ha Biological Tech Co. L in their 13F filings. The largest holders were UBS Group AG ($84), Morgan Stanley ($17) and Royal Bank of Canada ($0).
- Company
- Park Ha Biological Tech Co. L
- CUSIP
- G6925R110
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $101 |
| Exits | 0 | $0 |
Ownership 3 holders
| UBS Group AG | 0.00% | New | 80 | $84 |
| Morgan Stanley | 0.00% | New | 16 | $17 |
| Royal Bank of Canada | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is PARK HA BIOLOGICAL TECH CO L's weight in each manager's 13F, not the share of Park Ha Biological Tech Co. L the manager owns.